What Gets Measured Gets to Market, Safely and Swiftly
At Eskay Therapeutics Ltd, robust pharmaceutical analysis transcends mere data collection. It involves a profound expertise to interpret and transform data into actionable insights—whether that’s accelerating your R&D program, optimizing your cGMP manufacturing processes, or successfully submitting NDA/ANDA applications to market safe and effective drugs.
Our seasoned team employs an innovative approach to analytical services, specifically designed to streamline regulatory approvals. By demonstrating meticulous control and comprehensive understanding of the drug product and its development processes, we ensure the efficacy and safety of your pharmaceuticals. You can utilize these analytical capabilities as standalone services or integrate them into a full-scale drug development and manufacturing partnership with us. In either scenario, we guarantee timely delivery of superior results, allowing you to focus on your core work while we handle the complexities.
Request a Quote
Quality Our team utilizes cutting-edge chromatography and spectroscopy equipment, including ICP-MS and ICP-OES, to design and validate analytical methods that surpass the industry’s highest standards.
Speed Operational across our three facilities in strategic global locations, we are poised to meet your most demanding timelines and provide precise, client-specific analytical reporting.
Versatility Our network of over 60 QA/QC/Analytical specialists and cGMP-compliant facilities underpin our broad analytical service offerings, catering to a diverse range of client objectives.
Analytical Testing
Eskay Therapeutics provides rapid, high-quality analytical and microbiological testing for all types of drug substances and drug products, including APIs for compounding pharmacies.
Stability Services
Leveraging validated, on-site environmental chambers, our experts deliver custom or ICH-mandated stability data required for everything from early clinical batches to final packaged drug products.